Quanterix Corporation header image

Quanterix Corporation

QTRX

Equity

ISIN null / Valor 39127916

NASDAQ (2026-01-30)
USD 6.34-5.23%

Quanterix Corporation
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

Quanterix Corporation is a company focused on transforming healthcare by enhancing the precision and understanding of health to disease progression through advanced scientific research. It operates at the forefront of the healthcare industry, leveraging a combination of experienced management, leading scientists, and strategic investments to push the boundaries of precision health science. The company has established a significant global presence, serving hundreds of academic and industry clients with direct sales in North America and parts of Europe, while also reaching a wider international market through distributor partnerships. Quanterix offers a range of products and services designed to support the research needs of its customers, backed by a dedicated team of field application scientists and engineers providing comprehensive customer support worldwide. This approach underscores the company's commitment to advancing healthcare research and diagnostics through innovative technology and collaborative efforts.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

-33.7%1Y
-54.3%3Y
-90.2%5Y

Performance

80.7%1Y
72.1%3Y
83.6%5Y

Volatility

Market cap

296 M

Market cap (USD)

Daily traded volume (Shares)

511,995

Daily traded volume (Shares)

1 day high/low

11.04 / 10.715

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

The Platform Group AG
The Platform Group AG The Platform Group AG Valor: 57796644
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.28%EUR 4.25
Maternus-Kliniken AG
Maternus-Kliniken AG Maternus-Kliniken AG Valor: 335800
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.00%EUR 1.01
Ligand Pharmaceuticals Inc
Ligand Pharmaceuticals Inc Ligand Pharmaceuticals Inc Valor: 12015449
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.57%USD 192.10
Alkermes PLC
Alkermes PLC Alkermes PLC Valor: 13920929
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.84%USD 33.89
Outset Medical Inc
Outset Medical Inc Outset Medical Inc Valor: 56717137
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.18%USD 5.01
QuidelOrtho Corporation
QuidelOrtho Corporation QuidelOrtho Corporation Valor: 119356965
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.88%USD 27.17
iRhythm Technologies Inc
iRhythm Technologies Inc iRhythm Technologies Inc Valor: 34117792
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
3.70%USD 154.51
Novartis Inc
Novartis Inc Novartis Inc Valor: 1200526
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.30%CHF 114.62
PolyPeptide Group Ltd
PolyPeptide Group Ltd PolyPeptide Group Ltd Valor: 111076085
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.33%CHF 27.30
Savaria Corp
Savaria Corp Savaria Corp Valor: 1385257
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.96%CAD 23.70